Insights & Resources

Explore why profitable hospitals command higher valuations and how variability in transaction databases impacts fair market value.

Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

Learn about the risks of profit tunneling in nursing homes and why fair market value transactions help ensure compliance and financial integrity.

Health Savings Account contributions and distributions work to help you save on health care costs and maximize tax benefits for future needs.

Get ahead of the curve by looking back at emerging trends in 2024 that are likely to impact health care valuation in 2025 and beyond. Download Weaver Insights now.

The shortage of key health care providers is impacting health care services. We explore factors driving demand and how this affects valuations.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

Rising physician compensation and growing financial losses are putting health systems under pressure. Explore the 2024 trends and valuation insights.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.